Small-Molecule Transcription Factor Inhibitors in Oncology
Oncogenic transcription factors are an increasingly important target for anticancer therapies. Inhibiting these transcription factors could allow tumour cells to be reprogrammed, leading to apoptosis or differentiation from the malignant phenotype. As the use of kinase inhibitors is gradually declining, transcription factor inhibition is the next hot topic for oncology research and merits much attention.Small-Molecule Transcription Factor Inhibitors in Oncology highlights recent progress in the development of small-molecule inhibitors of oncogenic transcription factors. It also presents the evidence that this important protein class can be mo…
Mehr
CHF 234.00
Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)
V105:
Folgt in ca. 15 Arbeitstagen
Produktdetails
Weitere Autoren: Thurston, David E. (Hrsg.)
- ISBN: 978-1-78262-145-4
- EAN: 9781782621454
- Produktnummer: 19984441
- Verlag: Royal Society Of Chemistry
- Sprache: Englisch
- Erscheinungsjahr: 2018
- Seitenangabe: 199 S.
- Masse: H23.4 cm x B16.5 cm x D1.5 cm 454 g
- Reihenbandnummer: VOLU
- Gewicht: 454
2 weitere Werke von Khondaker Miraz (Hrsg.) Rahman:
Bewertungen
Anmelden